Q1 2019 Aldeyra Therapeutics Inc Earnings Call Transcript
Good morning and welcome to the Aldeyra Therapeutics First Quarter 2019 Financial Results and Corporate Update Conference Call. (Operator Instructions). Please note today's event is being recorded.
I would now like to turn the conference over to Joshua Reed, Chief Financial Officer. Please go ahead, sir.
Good morning, everyone. I'm Joshua Reed, Chief Financial Officer of Aldeyra Therapeutics and welcome to the Aldeyra Therapeutics conference call to discuss our first quarter 2019 financial results and corporate update.
With me today is Dr. Todd Brady, Chief Financial -- Chief Executive Officer of Aldeyra.
This conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include statements regarding Aldeyra's possible or assumed future results of operations, expenses and financial position, business strategies and plans, research development and commercial plans or expectations, trends, market sizing,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |